Literature DB >> 2296626

Effects of caffeine on alertness.

A Zwyghuizen-Doorenbos1, T A Roehrs, L Lipschutz, V Timms, T Roth.   

Abstract

The alerting effects of caffeine were assessed using a standard physiological measure of daytime sleepiness/alertness, the Multiple Sleep Latency Test (MSLT). Healthy young men (n = 24) were randomly assigned to receive caffeine 250 mg or placebo administered double blind, at 0900 and 1300 hours on each of 2 days. On the 3rd day both groups received placebo to test for conditioning to the alerting effects of caffeine. Each day sleep latency was measured at 1000, 1200, 1400, and 1600 hours and performance (divided attention at 1030 hours and auditory vigilance at 1430 hours) was assessed. Caffeine increased sleep latency (i.e., improved alertness) and auditory vigilance performance compared to placebo. Tolerance to the effects of caffeine on sleep latency developed over the four administrations. On the conditioning test (day 3) the group receiving caffeine the previous two days was more alert and performed better than the placebo group.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296626     DOI: 10.1007/bf02245786

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  Dose-related sleep disturbances induced by coffee and caffeine.

Authors:  I Karacan; J I Thornby; M Anch; G H Booth; R L Williams; P J Salis
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

3.  The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans.

Authors:  L D Chait; E H Uhlenhuth; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness.

Authors:  M A Carskadon; W C Dement; M M Mitler; T Roth; P R Westbrook; S Keenan
Journal:  Sleep       Date:  1986-12       Impact factor: 5.849

5.  Effects of caffeine and cyclizine alone and in combination on human performance, subjective effects and EEG activity.

Authors:  M Clubley; C E Bye; T A Henson; A W Peck; C J Riddington
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

6.  Sensitization to the behavioral effects of cocaine: modification by Pavlovian conditioning.

Authors:  R E Hinson; C X Poulos
Journal:  Pharmacol Biochem Behav       Date:  1981-10       Impact factor: 3.533

7.  Classical conditioning, decay and extinction of cocaine-induced hyperactivity and stereotypy.

Authors:  G A Barr; N S Sharpless; S Cooper; S R Schiff; W Paredes; W H Bridger
Journal:  Life Sci       Date:  1983-10-03       Impact factor: 5.037

8.  Tolerance to the humoral and hemodynamic effects of caffeine in man.

Authors:  D Robertson; D Wade; R Workman; R L Woosley; J A Oates
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

9.  The multiple sleep latency test: what does it measure?

Authors:  M A Carskadon; W C Dement
Journal:  Sleep       Date:  1982       Impact factor: 5.849

10.  Ethanol and caffeine effects on daytime sleepiness/alertness.

Authors:  M Lumley; T Roehrs; D Asker; F Zorick; T Roth
Journal:  Sleep       Date:  1987-08       Impact factor: 5.849

View more
  24 in total

1.  Central and peripheral effects of sustained caffeine use: tolerance is incomplete.

Authors:  Joanne Watson; Ian Deary; David Kerr
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

2.  Effects of expectation and caffeine on arousal, well-being, and reaction time.

Authors:  Rainer Schneider; Mauritz Grüner; Alexandra Heiland; Martina Keller; Zuzana Kujanová; Martin Peper; Maximilian Riegl; Stefan Schmidt; Petra Volz; Harald Walach
Journal:  Int J Behav Med       Date:  2006

Review 3.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

4.  Effects of caffeine on cognition and mood without caffeine abstinence.

Authors:  D M Warburton
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

5.  A specific role for the thalamus in mediating the interaction of attention and arousal in humans.

Authors:  C M Portas; G Rees; A M Howseman; O Josephs; R Turner; C D Frith
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

6.  The effects of caffeine on ambulatory blood pressure, heart rate, and mood in coffee drinkers.

Authors:  P J Green; J Suls
Journal:  J Behav Med       Date:  1996-04

7.  Sleep duration and its correlates in middle-aged and elderly Chinese women: the Shanghai Women's Health Study.

Authors:  Xiangdong Tu; Hui Cai; Yu-Tang Gao; Xiaoyan Wu; Bu-Tian Ji; Gong Yang; Honglan Li; Wei Zheng; Xiao Ou Shu
Journal:  Sleep Med       Date:  2012-08-28       Impact factor: 3.492

8.  Caffeine reversal of sleep deprivation effects on alertness and mood.

Authors:  D Penetar; U McCann; D Thorne; G Kamimori; C Galinski; H Sing; M Thomas; G Belenky
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed.

Authors:  Christopher Drake; Timothy Roehrs; John Shambroom; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.